YU21501A - Novi derivati benzoilgvanidina sa svojstvima koja imaju prednost, postupak za njihovo pripremanje i njihova primena u pripremanju lekova - Google Patents
Novi derivati benzoilgvanidina sa svojstvima koja imaju prednost, postupak za njihovo pripremanje i njihova primena u pripremanju lekovaInfo
- Publication number
- YU21501A YU21501A YU21501A YU21501A YU21501A YU 21501 A YU21501 A YU 21501A YU 21501 A YU21501 A YU 21501A YU 21501 A YU21501 A YU 21501A YU 21501 A YU21501 A YU 21501A
- Authority
- YU
- Yugoslavia
- Prior art keywords
- medicaments
- producing
- production
- advantageous properties
- benzoylguanidine derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/32—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D207/325—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals directly attached to the ring nitrogen atom
- C07D207/327—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/81—Amides; Imides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
- C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
- C07D295/182—Radicals derived from carboxylic acids
- C07D295/192—Radicals derived from carboxylic acids from aromatic carboxylic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
Abstract
Ovaj se pronalazak odnosi na novu vrstu derivata benzoilgvanidina, opšte formule (I), na postupak za njihovo pripremanje i na njihovu primenu za pripremanje lekova.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19843489A DE19843489B4 (de) | 1998-09-22 | 1998-09-22 | Benzoylguanidin-Abkömmlinge mit vorteilhaften Eigenschaften, Verfahren zu ihrer Herstellung und ihre Verwendung bei der Herstellung von Arzneimitteln, sowie diese enthaltende pharmazeutische Zubereitung |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| YU21501A true YU21501A (sh) | 2004-03-12 |
| RS49971B RS49971B (sr) | 2008-09-29 |
Family
ID=7881872
Country Status (35)
| Country | Link |
|---|---|
| EP (1) | EP1165534B1 (sh) |
| JP (1) | JP3817425B2 (sh) |
| KR (1) | KR100621821B1 (sh) |
| CN (1) | CN1166654C (sh) |
| AR (1) | AR023668A1 (sh) |
| AT (1) | ATE288425T1 (sh) |
| AU (1) | AU764819C (sh) |
| BG (1) | BG64985B1 (sh) |
| BR (1) | BR9913107A (sh) |
| CA (1) | CA2345006C (sh) |
| CO (1) | CO5150207A1 (sh) |
| CZ (1) | CZ300158B6 (sh) |
| DE (2) | DE19843489B4 (sh) |
| EA (1) | EA004687B1 (sh) |
| EE (1) | EE04749B1 (sh) |
| EG (1) | EG23757A (sh) |
| ES (1) | ES2237951T3 (sh) |
| HK (1) | HK1043367B (sh) |
| HR (1) | HRP20010194B1 (sh) |
| HU (1) | HU228955B1 (sh) |
| ID (1) | ID27759A (sh) |
| IL (1) | IL141805A (sh) |
| MY (1) | MY121362A (sh) |
| NO (1) | NO317993B1 (sh) |
| NZ (1) | NZ511167A (sh) |
| PE (1) | PE20001085A1 (sh) |
| PL (1) | PL195291B1 (sh) |
| PT (1) | PT1165534E (sh) |
| RS (1) | RS49971B (sh) |
| SA (1) | SA99200474B1 (sh) |
| SK (1) | SK285578B6 (sh) |
| TR (1) | TR200100801T2 (sh) |
| TW (1) | TWI221841B (sh) |
| WO (1) | WO2000017176A2 (sh) |
| ZA (1) | ZA200101212B (sh) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6730678B2 (en) * | 2001-02-15 | 2004-05-04 | Boehringer Ingelheim Pharma Kg | Benzoylguanidine salt and hydrates thereof |
| DE10106970A1 (de) * | 2001-02-15 | 2002-08-29 | Boehringer Ingelheim Pharma | Neues Benzoylguanidinsalz |
| US6982256B2 (en) | 2001-09-07 | 2006-01-03 | Boehringer Ingelheim Pharma Kg | Tolerance of 4-(4-(2-pyrrolylcarbonyl)-1-piperazinyl)-3-trifluoromethyl-benzoylguanidine in intravenous administration |
| DE10144030A1 (de) * | 2001-09-07 | 2003-03-27 | Boehringer Ingelheim Pharma | Verbesserung der lokalen Verträglichkeit bei intravenöser Verabreichung von 4-(4-(2-Pyrrolylcarbonyl-1-piperazinyl)-3-trifluormethyl-benzoylguanidin |
| FR2871157A1 (fr) * | 2004-06-04 | 2005-12-09 | Aventis Pharma Sa | Produits biaryl aromatiques, compositions les contenant et utilisation |
| US20110118262A1 (en) * | 2008-07-08 | 2011-05-19 | Boehringer Ingelheim International Gmbh | Pyrrolidinyl and Piperidinyl Compounds Useful as NHE-1 Inhibitiors |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19601303A1 (de) * | 1996-01-16 | 1997-07-17 | Boehringer Ingelheim Kg | Neuartige Benzoylguanidin-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung bei der Herstellung von Arzneimitteln |
-
1998
- 1998-09-22 DE DE19843489A patent/DE19843489B4/de not_active Expired - Fee Related
-
1999
- 1999-08-17 SA SA99200474A patent/SA99200474B1/ar unknown
- 1999-09-16 CA CA002345006A patent/CA2345006C/en not_active Expired - Fee Related
- 1999-09-16 PT PT99952453T patent/PT1165534E/pt unknown
- 1999-09-16 PL PL99347234A patent/PL195291B1/pl unknown
- 1999-09-16 ID IDW20010663A patent/ID27759A/id unknown
- 1999-09-16 EA EA200100317A patent/EA004687B1/ru not_active IP Right Cessation
- 1999-09-16 AT AT99952453T patent/ATE288425T1/de active
- 1999-09-16 HU HU0200225A patent/HU228955B1/hu not_active IP Right Cessation
- 1999-09-16 EP EP99952453A patent/EP1165534B1/de not_active Expired - Lifetime
- 1999-09-16 NZ NZ511167A patent/NZ511167A/en not_active IP Right Cessation
- 1999-09-16 CZ CZ20011047A patent/CZ300158B6/cs not_active IP Right Cessation
- 1999-09-16 IL IL14180599A patent/IL141805A/xx not_active IP Right Cessation
- 1999-09-16 AU AU64659/99A patent/AU764819C/en not_active Ceased
- 1999-09-16 KR KR1020017003627A patent/KR100621821B1/ko not_active IP Right Cessation
- 1999-09-16 JP JP2000574086A patent/JP3817425B2/ja not_active Expired - Fee Related
- 1999-09-16 ES ES99952453T patent/ES2237951T3/es not_active Expired - Lifetime
- 1999-09-16 SK SK396-2001A patent/SK285578B6/sk not_active IP Right Cessation
- 1999-09-16 TR TR2001/00801T patent/TR200100801T2/xx unknown
- 1999-09-16 WO PCT/EP1999/006857 patent/WO2000017176A2/de active IP Right Grant
- 1999-09-16 BR BR9913107-2A patent/BR9913107A/pt not_active IP Right Cessation
- 1999-09-16 RS YUP-215/01A patent/RS49971B/sr unknown
- 1999-09-16 DE DE59911568T patent/DE59911568D1/de not_active Expired - Lifetime
- 1999-09-16 CN CNB998111430A patent/CN1166654C/zh not_active Expired - Fee Related
- 1999-09-16 EE EEP200100178A patent/EE04749B1/xx not_active IP Right Cessation
- 1999-09-20 PE PE1999000949A patent/PE20001085A1/es not_active Application Discontinuation
- 1999-09-20 MY MYPI99004064A patent/MY121362A/en unknown
- 1999-09-21 CO CO99059852A patent/CO5150207A1/es unknown
- 1999-09-22 AR ARP990104775A patent/AR023668A1/es not_active Ceased/Invalidation/Refusal/Rejection/Nullification
- 1999-09-22 TW TW088116279A patent/TWI221841B/zh not_active IP Right Cessation
- 1999-09-22 EG EG118099A patent/EG23757A/xx active
-
2001
- 2001-02-13 ZA ZA200101212A patent/ZA200101212B/en unknown
- 2001-03-09 BG BG105326A patent/BG64985B1/bg active Active
- 2001-03-15 HR HR20010194A patent/HRP20010194B1/xx not_active IP Right Cessation
- 2001-03-21 NO NO20011428A patent/NO317993B1/no not_active IP Right Cessation
-
2002
- 2002-07-08 HK HK02105065.7A patent/HK1043367B/zh not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JO2707B1 (ar) | مشتقات ثيوفين جليكوسايد جديدة, طرق تحضيرها, والادوية المحتوية على هذه المركبات واستخدامها | |
| MEP9309A (en) | Novel oligosaccharides, preparation method and pharmaceutical compositions containing the same | |
| ME00376B (me) | DIHIDROPTERIDINONI, POSTUPAK ZA NJlHOVO PRIPREMANJE I NJlHOVA PRIMJENA KAO LIJEK | |
| HRP990167B1 (en) | Sulphinic acid derivatives, method for producing them, and their use | |
| MY133392A (en) | Novel substituted pyrazole derivatives | |
| RS20050019A (en) | Heterocyclically substituted benzoylureas,method for their production and their use as medicaments | |
| ATE147736T1 (de) | Benzopyranone, verfahren zu ihrer herstellung und verwendung | |
| YU133090A (sh) | Novi heteroazepini s paf-antaganostičnim učinkom in postopek za njihovo pripravo | |
| YU56302A (sh) | Derivati 8,8a-dihidro-indeno/1,2-d/taizola, koji su supstituisani u 8a-položaju,postupak za njihovu proizvodnju i njihova primena kod leka npr.kao anorektičnog sredstva | |
| MXPA03009548A (es) | Arilsulfonamidas como agentes antivirales. | |
| BR0111266A (pt) | Sìntese reduzida de derivados de 3,3-diarilpropilamina | |
| HK1068813A1 (en) | Method for the production of solid formulations of sodium 3-hydroxy-3- methylbutyrate | |
| YU63696A (sh) | Novi fenilamidin-derivati, postupci za njihovo pripremanje i njihova primena kao lekova | |
| HUP0201589A2 (hu) | Eljárás monodiszperz gélformájú kationcserélők előállítására | |
| YU21501A (sh) | Novi derivati benzoilgvanidina sa svojstvima koja imaju prednost, postupak za njihovo pripremanje i njihova primena u pripremanju lekova | |
| YU37597A (sh) | Novi derivati piranozida | |
| HUP0303319A2 (hu) | 9-Dezoxo-9-dihidro-9a-aza-9a-homoeritromicin A és 5-O-dezozaminil-9-dezoxo-9-dihidro-9a-aza-9a-homoeritronolid A 9a-N-[N'-(fenil-szulfonil)karbamoil]-származékai, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények | |
| ATE446952T1 (de) | Herstellungsverfahren von 2-cyanopyridinen | |
| YU14094A (sh) | Postupak za proizvodnju aminometan-fosfonaste kiseline | |
| YU74401A (sh) | Postupak za dobijanje 2s-3-amino-3-arilpropionske kiseline i njenih derivata | |
| WO1997022368A3 (de) | Kovalente lipid-phosphonocarbonsäure-konjugate und ihre anwendung wie antivirale arzneimittel | |
| PT1000952E (pt) | Novos derivados 2-halogenados de 5-o-desosaminileritronolida a, processo de preparação e sua utilização como medicamentos | |
| DE69627184D1 (de) | 3-aminoethyl-n-amidino-2,5-dihydropyrrol derivative mit arginine-mimetischen eigenschaften | |
| MXPA03003466A (es) | Derivados de piranosido. | |
| MXPA04001856A (es) | Indan-1-oles c2-sustituidos y sus derivados, metodo para su produccion y su uso como medicamentos. |